These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18728400)

  • 21. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition.
    Borg NA; Ely LK; Beddoe T; Macdonald WA; Reid HH; Clements CS; Purcell AW; Kjer-Nielsen L; Miles JJ; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2005 Feb; 6(2):171-80. PubMed ID: 15640805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting peptide binding to Major Histocompatibility Complex molecules.
    Liao WW; Arthur JW
    Autoimmun Rev; 2011 Jun; 10(8):469-73. PubMed ID: 21333759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen recognition and presentation by dendritic cells.
    Inaba K; Inaba M
    Int J Hematol; 2005 Apr; 81(3):181-7. PubMed ID: 15814328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The peptidic self model: a reassessment of the role of the major histocompatibility complex molecules in the restriction of the T-cell response.
    Claverie JM; Kourilsky P
    Ann Inst Pasteur Immunol; 1986; 137D(3):425-42. PubMed ID: 3103648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capture and processing of exogenous antigens for presentation on MHC molecules.
    Watts C
    Annu Rev Immunol; 1997; 15():821-50. PubMed ID: 9143708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC specificity of iIELs.
    Das G; Janeway CA
    Trends Immunol; 2003 Feb; 24(2):88-93. PubMed ID: 12547506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved ligand discrimination by force-induced unbinding of the T cell receptor from peptide-MHC.
    Klotzsch E; Schütz GJ
    Biophys J; 2013 Apr; 104(8):1670-5. PubMed ID: 23601314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of T cells by antigen-presenting cells is kinetically controlled by antigenic peptide binding to major histocompatibility complex class II molecules.
    McConnell HM; Wada HG; Arimilli S; Fok KS; Nag B
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2750-4. PubMed ID: 7708718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting interactions between T cell receptors and MHC-peptide complexes.
    Roomp K; Domingues FS
    Mol Immunol; 2011 Jan; 48(4):553-62. PubMed ID: 21106246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of a functional antigen-Ia complex.
    Srinivasan M; Pierce SK
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):919-22. PubMed ID: 2153978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic core amino acids of an immunodominant allopeptide are important for MHC binding and TCR recognition.
    Sitaru AG; Timmermann W; Ulrichs K; Otto C
    Hum Immunol; 2004 Aug; 65(8):817-25. PubMed ID: 15336783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic peptide interaction with MHC molecules: implications for the design of artificial vaccines.
    Berzofsky JA
    Semin Immunol; 1991 Jul; 3(4):203-16. PubMed ID: 1932704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands.
    Kersh GJ; Allen PM
    J Exp Med; 1996 Oct; 184(4):1259-68. PubMed ID: 8879197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex.
    Beringer DX; Kleijwegt FS; Wiede F; van der Slik AR; Loh KL; Petersen J; Dudek NL; Duinkerken G; Laban S; Joosten A; Vivian JP; Chen Z; Uldrich AP; Godfrey DI; McCluskey J; Price DA; Radford KJ; Purcell AW; Nikolic T; Reid HH; Tiganis T; Roep BO; Rossjohn J
    Nat Immunol; 2015 Nov; 16(11):1153-61. PubMed ID: 26437244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costimulation and endogenous MHC ligands contribute to T cell recognition.
    Wülfing C; Sumen C; Sjaastad MD; Wu LC; Dustin ML; Davis MM
    Nat Immunol; 2002 Jan; 3(1):42-7. PubMed ID: 11731799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Processing of a minimal antigenic peptide alters its interaction with MHC molecules.
    Fox BS; Carbone FR; Germain RN; Paterson Y; Schwartz RH
    Nature; 1988 Feb; 331(6156):538-40. PubMed ID: 2448649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.